Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€89.00
07.08.26
€91.12
07.08.27
2.13%
20.08.26

TD Cowen 
07.08.26 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€78.42
07.08.26
€99.80
07.08.27
15.91%
20.08.26

HC Wainwright 
07.08.26 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€71.72
03.08.26
€150.00
30.09.28
26.38%
20.08.26

Could be very worthwhile Investment >20% year
BiotechBee 
03.08.26 80%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€68.12
21.07.26
-
21.07.27
33.44%
20.08.26

Benchmark Co. 
21.07.26 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€59.24
16.06.26
-
16.06.27
53.44%
20.08.26

HC Wainwright 
16.06.26 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€59.58
03.06.26
-
03.06.27
52.57%
20.08.26

Benchmark Co. 
03.06.26 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€59.58
03.06.26
-
03.06.27
52.57%
20.08.26

UBS Group AG 
03.06.26 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€62.02
12.05.26
€79.10
12.05.27
46.57%
20.08.26

Morgan Stanley 
12.05.26 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€54.90
29.04.26
€81.13
29.04.27
65.57%
20.08.26

HC Wainwright 
29.04.26 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€60.94
19.02.26
€76.30
19.02.27
49.16%
20.08.26

Benchmark Co. 
19.02.26 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€61.94
18.02.26
-
18.02.27
46.75%
20.08.26

TD Cowen 
18.02.26 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€64.40
03.02.26
-
03.02.27
41.15%
20.08.26

Benchmark Co. 
03.02.26 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€60.40
29.01.26
-
29.01.27
50.50%
20.08.26

HC Wainwright 
29.01.26 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€62.16
08.01.26
€77.09
08.01.27
46.24%
20.08.26

TD Cowen 
08.01.26 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€55.96
19.12.25
€76.74
19.12.26
62.44%
20.08.26

HC Wainwright 
19.12.25 50%
sell
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€53.66
04.12.25
€48.01
04.12.26
69.40%
20.08.26

The Goldman Sachs Group, Inc. 
04.12.25 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€63.20
28.11.25
€77.69
28.11.26
43.83%
20.08.26

HC Wainwright 
28.11.25 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€60.12
16.11.25
-
16.11.26
50.77%
20.08.26

StockNews.com 
16.11.25 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€60.96
13.11.25
-
13.11.26
1.87%
18.02.26

RudolfL 
13.11.25 0%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€57.14
21.10.25
-
21.10.26
59.08%
20.08.26

HC Wainwright 
21.10.25 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€57.80
20.10.25
€67.75
20.10.26
57.27%
20.08.26

Morgan Stanley 
20.10.25 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€59.00
15.10.25
€77.45
15.10.26
54.07%
20.08.26

HC Wainwright 
15.10.25 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€61.58
02.10.25
€76.67
02.10.26
47.61%
20.08.26

HC Wainwright 
02.10.25 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€66.40
24.09.25
€76.27
24.09.26
36.90%
20.08.26

Benchmark Co. 
24.09.25 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€65.96
22.09.25
€72.45
22.09.26
37.81%
20.08.26

HC Wainwright 
22.09.25 50%